Please login to the form below

Not currently logged in
Email:
Password:

Nestle Health Science

This page shows the latest Nestle Health Science news and features for those working in and with pharma, biotech and healthcare.

Nestlé Health Science invests $145m in food allergy biotech

Nestlé Health Science invests $145m in food allergy biotech

Nestlé Health Science has taken a $145m stake in a US biotech whose lead product is a peanut allergy treatment that has Breakthrough Therapy Designation from the US FDA. . ... The deal will also see Nestlé Health Science's CEO Greg Behar take a seat

Latest news

  • Nestlé Health Science buys medical device firm Nestlé Health Science buys medical device firm

    Acquisition of UK's Phagenesis expected to be completed by 2019. Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical ... Greg Behar, chief executive at Nestlé Health Science, said:

  • Nestlé begins mHealth trial Nestlé begins mHealth trial

    Launches trials in healthly ageing research programme. Nestlé has launched a two-year clinical trial in China to evaluate the impact of nutrition and physical activity on mobility in healthy ageing ... The firm has joined with Medidata for the study,

  • Nestle continues pharma drive with Seres collaboration Nestle continues pharma drive with Seres collaboration

    The terms of the agreement give Nestle Health Science rights to four Seres programmes for Clostridium difficile infection (CDI) and IBD - which includes Crohn's disease and ulcerative colitis - outside the ... Meanwhile, Nestle Health Science has made a

  • Lifestyle choices of consumer health Lifestyle choices of consumer health

    Nestlé:Nestlé Health Science is a fully owned subsidiary of Nestlé and aims to 'pioneer a new industry between the traditional nutrition and pharmaceutical industries through the development of science-based ... In November 2012, it was announced that

  • Big Pharma or Big Food? Insights on the nutraceuticals debate Big Pharma or Big Food? Insights on the nutraceuticals debate

    their systems, interest in the science-based nutritional market is clearly one to watch. ... Nestlé Health Science has hit the ground running since its inception in 2011.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    licence, collaboration. 167. Aimmune Therapeutics/ Nestlé Health Science. CODIT (Characterised Oral Desensitisation ImmunoTherapy), for treating life-threatening food. ... acquisition of 85.1% stake. 60. Broad Institute/ IBM Watson Health. reserch

  • SEO for the healthcare industry SEO for the healthcare industry

    internet. More than half of millennials said they search online for health information before seeing a doctor. ... is head of digital marketing for Vitaflo - a Nestlé health science company. .

  • Deal Watch February 2016 Deal Watch February 2016

    by Nestlé Health Science into Pronutria Biosciences is worthy of note as it represents a relatively new player in the field. ... licence. 44.5. Pronutria Biosciences/ Nestlé Health Science. medicines for serious conditions linked to amino acid imbalance

  • Deal Watch January 2016 Deal Watch January 2016

    Nestlé has paid $120m upfront and will cover some development costs including one third of late stage development costs. ... 32, 000. Seres Therapeutics/ Nestle Health Science. Collaboration. Rights to market products including SER 262 (p1 for

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Random42 Scientific Communication

    Mesoblast. Mundipharma. NAPP. National Geographic. NHS. Nestle Health Science. Novartis. Novartis Vaccines and Diagnostics. ... Join Random42 Scientific Communication in London this Thursday 9th March for WIRED Health 2017.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics